Literature DB >> 26299954

Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Ming-hui Li1, Sheng-bo Fu1, Hua-sheng Xiao1.   

Abstract

Cancer is an extremely diverse and complex disease that results from various genetic and epigenetic changes such as DNA copy-number variations, mutations, and aberrant mRNA and/or protein expression caused by abnormal transcriptional regulation. The expression profiles of certain microRNAs (miRNAs) and messenger RNAs (mRNAs) are closely related to cancer progression stages. In the past few decades, DNA microarray and next-generation sequencing techniques have been widely applied to identify miRNA and mRNA signatures for cancers on a genome-wide scale and have provided meaningful insights into cancer diagnosis, prognosis and personalized medicine. In this review, we summarize the progress in genome-wide analysis of miRNAs and mRNAs as cancer biomarkers, highlighting their diagnostic and prognostic roles.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26299954      PMCID： PMC4648178          DOI： 10.1038/aps.2015.67

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


  194 in total

1.  Impact of normalization on miRNA microarray expression profiling.

Authors:  Sylvain Pradervand; Johann Weber; Jérôme Thomas; Manuel Bueno; Pratyaksha Wirapati; Karine Lefort; G Paolo Dotto; Keith Harshman
Journal:  RNA       Date:  2009-01-28       Impact factor: 4.942

2.  Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer.

Authors:  Fulya Yaman Agaoglu; Müge Kovancilar; Yavuz Dizdar; Emin Darendeliler; Stefan Holdenrieder; Nejat Dalay; Ugur Gezer
Journal:  Tumour Biol       Date:  2011-01-28

3.  Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection.

Authors:  X Zhang; Z Yan; J Zhang; L Gong; W Li; J Cui; Y Liu; Z Gao; J Li; L Shen; Y Lu
Journal:  Ann Oncol       Date:  2011-02-22       Impact factor: 32.976

4.  Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.

Authors:  H J Berkel; E A Turbat-Herrera; R Shi; A de Benedetti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

5.  High-throughput RNA sequencing in B-cell lymphomas.

Authors:  Wenming Xiao; Bao Tran; Louis M Staudt; Roland Schmitz
Journal:  Methods Mol Biol       Date:  2013

6.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.

Authors:  Richard Flavin; Paul Smyth; Ciara Barrett; S Russell; Hannah Wen; Jianjun Wei; Alex Laios; Sharon O'Toole; M Ring; K Denning; J Li; S Aherne; D Sammarae; N A Aziz; A Alhadi; Sephen P Finn; M Loda; Sheppard B; Orla Sheils; John J O'Leary
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

9.  Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling.

Authors:  Xiaofeng Dai; Ana Chen; Zhonghu Bai
Journal:  Sci Rep       Date:  2014-10-23       Impact factor: 4.379

10.  Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.

Authors:  Tao Huang; Jing Yang; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411
View more
  25 in total

1.  Precision cancer medicine: where to target?

Authors:  Qiang Yu; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

2.  MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.

Authors:  Valeria Canu; Andrea Sacconi; Laura Lorenzon; Francesca Biagioni; Federica Lo Sardo; Maria Grazia Diodoro; Paola Muti; Alfredo Garofalo; Sabrina Strano; Antonietta D'Errico; Gian Luca Grazi; Mario Cioce; Giovanni Blandino
Journal:  Oncotarget       Date:  2017-05-02

3.  MicroRNA Expression and Correlation with mRNA Levels of Colorectal Cancer-Related Genes.

Authors:  Farahnaz Moghadamnia; Pegah Ghoraeian; Sara Minaeian; Atefeh Talebi; Farnaz Farsi; Abolfazl Akbari
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 4.  Current methodologies for molecular screening of thyroid nodules.

Authors:  Elisabetta Macerola; Fulvio Basolo
Journal:  Gland Surg       Date:  2018-08

5.  MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1.

Authors:  Haitao Luo; Caixia Liang
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

6.  Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.

Authors:  Nathaniel Weygant; Yang Ge; Dongfeng Qu; John S Kaddis; William L Berry; Randal May; Parthasarathy Chandrakesan; Edwin Bannerman-Menson; Kenneth J Vega; James J Tomasek; Michael S Bronze; Guangyu An; Courtney W Houchen
Journal:  Cancer Res       Date:  2016-06-10       Impact factor: 12.701

7.  Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas.

Authors:  Likun Hou; Jian Chen; Yuhui Zheng; Chunyan Wu
Journal:  Tumour Biol       Date:  2015-11-09

8.  miR-TV: an interactive microRNA Target Viewer for microRNA and target gene expression interrogation for human cancer studies.

Authors:  Chao-Yu Pan; Wen-Chang Lin
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

9.  MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.

Authors:  Hai-Ting Liu; Ai-Yan Xing; Xu Chen; Ran-Ran Ma; Ya-Wen Wang; Duan-Bo Shi; Hui Zhang; Peng Li; Hong-Fang Chen; Yu-Hong Li; Peng Gao
Journal:  Oncotarget       Date:  2015-11-10

10.  miR-18a-5p Targets FBP1 to Promote Proliferation, Migration, and Invasion of Liver Cancer Cells and Inhibit Cell Apoptosis.

Authors:  Shan Gao; Dongjie Zhu; Jian Zhu; Lianqiang Shen; Ming Zhu; Xuefeng Ren
Journal:  Comput Math Methods Med       Date:  2021-06-14       Impact factor: 2.238
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.